Drug firm faces big fine over market tactics
A drug company whose treatment for a rare enzyme disease costs more than £60,000 a year for the average adult patient faces big fines for allegedly abusing its dominant position in the market.
Irritable male syndrome
Flagging men can now boost their testosterone levels. Robin McKie asks whether it's worth the risk.